Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.63 |
| ▸ | SQLE | Q14534 | 7/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | ICMT | O60725 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7589665 | 1.00 | KMT2A (0.64) | KMT2AALOX15MAPTMEN1CYP3A4 | |
| SCHEMBL7562565 | 1.00 | KMT2A (0.64) | KMT2AALOX15MAPTMEN1CYP3A4 | |
| SCHEMBL7562570 | 1.00 | KMT2A (0.64) | KMT2AALOX15MAPTMEN1CYP3A4 | |
| SCHEMBL7560079 | 0.91 | TSHR (0.54) | KMT2AALOX15MAPTMEN1CYP3A4 | |
| SCHEMBL9474487 | 0.86 | SQLE (0.70) | KMT2AALOX15MAPTMEN1CYP3A4 | |
| SCHEMBL9474498 | 0.86 | SQLE (0.70) | KMT2AALOX15MAPTMEN1CYP3A4 | |
| SCHEMBL28588501 | 0.83 | KMT2A (0.64) | KMT2AALOX15MAPTMEN1CYP3A4 | |
| SCHEMBL29462483 | 0.83 | KMT2A (0.64) | KMT2AALOX15MAPTMEN1CYP3A4 | |
| SCHEMBL83307 | 0.83 | KMT2A (0.64) | KMT2AALOX15MAPTMEN1CYP3A4 | |
| SCHEMBL160736 | 0.83 | KMT2A (0.64) | KMT2AALOX15MAPTMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023009610-A1 | METHODS FOR SYNTHESIS OF RACEMIC, SCALEMIC, AND CHIRAL ALPHA-TOCOTRIENOL QUINONE | PTC THERAPEUTICS, INC. (US) | 2023-02-02 | — | — | WO | disclosed |
| EP-1013652-B1 | Process for preparation of substituted chromanderivatives | BASF AG (DE) | 2002-08-14 | — | — | EP | disclosed |
| EP-1013652-A2 | Process for preparation of substituted chromanderivatives | BASF AKTIENGESELLSCHAFT (DE) | 2000-06-28 | — | — | EP | disclosed |